Imperial College London contributes to the development of global standards for the treatment of diabetes

The Diabetes Center of Imperial College London's integrated health care network in Mubadala, in cooperation with the International Society for Health Performance Measurement (ICHOM), jointly defined a set of global standards for patients with type 1 and 2 diabetes.

The new standards were launched on the occasion of World Diabetes Day 2018, corresponding to November 14 of each year, after a year of coordination and joint action with the International Organization.

The new set of global standards defines health outcomes that focus on the most important outcomes for people with type I and type II diabetes.

It is a reliable repertoire of reliable data that physicians can reference and integrate into their disease control programs and plans, ensuring value-based and patient-centered health care.

The members of the 28-member working group of the International Association of Health Metrology worked together to monitor the results of the standards.

Medical experts, researchers and patients from 19 countries participated in the discussion and study of each outcome as part of a structured process. The final list of health effects was included in all standards and approved by 176 experts from 22 countries and 128 diabetic patients from four countries.

The results represent a combination of clinical measures and data based on their priorities, including mental health and psychological stress caused by diabetes, depression and glycemic control, as well as diabetic ketoacidosis and chronic complications. in particular Affects the nervous system and the circulatory system.

Other findings are related to health services, such as financial barriers to treatment and access to health care. The set of criteria also includes specific tools and timelines for measuring each result.

"We are proud to be one of the major contributors to the success of this important initiative to improve the fight against diabetes," said Dr. Safdar Naqvi, a medical doctor, consultant endocrinologist at the University of Ottawa. Imperial College London Diabetes Center. In the United Arab Emirates, but in the whole world, in line with the vision of the United Arab Emirates 2021 ".

"We are at the forefront of developing an integrated approach to value-based therapy that can make a positive difference in the clinical and therapeutic procedures of diabetes," Dr. Naqvi added.

"The new set of global standards will allow healthcare providers to leverage our resources and expertise to achieve the best possible results."

He emphasized that this initiative would contribute to the improvement of diabetes care services in a safe, effective and affordable way, based on evidence-based treatment.

Mona Khalid, Vice President of the International Society for Health Outcomes Measurement, Research and Product Development, said: "We were very pleased with the support provided by the Imperial College London Diabetes Center. in terms of funding, expertise and clinical services.

"This achievement demonstrates the commitment of both parties to improve the consistency and transparency of measuring the health effects of diabetes, as well as a first step toward developing a better understanding of how diabetes works. a set of standardized global standards aimed at improving patient care and helping them adopt a healthy lifestyle. " .